Targeted Nanostructured Lipid Carrier-Mediated Flavonoid Delivery for Enhanced Therapeutic Efficacy in Non-Small Cell Lung Cancer (NSCLC). APIMR. 2026;1(1):73-97. Accessed July 16, 2026. https://apimr.nknpub.com/1/article/view/4